2 results match your criteria: "CT and VA Medical Center[Affiliation]"
Immunotherapy-Related Acute Kidney Injury.
Adv Chronic Kidney Dis
September 2021
Section of Nephrology, Yale University School of Medicine, New Haven, CT and VA Medical Center, Section of Nephrology, West Have, CT.
Nephrotoxicity associated with immunotherapy is increasingly being encountered in clinical practice. Drugs that augment the immune system to eradicate cancer are revolutionary in the field of oncology. Older generation immunotherapies such as high-dose interleukin and interferon-alpha are now being replaced with more effective immune checkpoint inhibitors and chimeric antigen receptor T-cell therapies, which have shown promising results in numerous clinical trials.
View Article and Find Full Text PDFLong-term risk of chronic kidney disease and mortality in children after acute kidney injury: a systematic review.
BMC Nephrol
November 2014
Department of Internal Medicine, Section of Nephrology, New Haven, CT and VA Medical Center, Yale University School of Medicine, West Haven, CT, USA.
Background: Acute kidney injury (AKI) is associated with significant short-term morbidity and mortality in children. However, the risk for long-term outcomes after AKI is largely unknown.
Methods: We performed a systematic review and meta-analysis to determine the cumulative incidence rate of proteinuria, hypertension, decline in glomerular filtration rate (GFR), and mortality after an episode of AKI.